Výsledky vyhledávání - Jeremy R. Jackson
- Zobrazuji výsledky 1 - 4 z 4
-
1
The MDM2 small-molecule inhibitor RG7388 leads to potent tumor inhibition in p53 wild-type neuroblastoma Autor Anna Lakoma, Eveline Barbieri, Saurabh Agarwal, Jeremy R. Jackson, Z Chen, Yong Ho Kim, Matthew C. McVay, Jason M. Shohet, Eugene S. Kim
Vydáno 2015Artigo -
2
<scp>C</scp>olony stimulating factor 1 receptor blockade improves the efficacy of chemotherapy against human neuroblastoma in the absence of T lymphocytes Autor Matthew W. Webb, Jianping Sun, Michael A. Sheard, Wei‐Yao Liu, Hongwei Wu, Jeremy R. Jackson, Jemily Malvar, Richard Sposto, Dylan Daniel, Robert C. Seeger
Vydáno 2018Artigo -
3
Activated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary Neuroblastoma Autor Wesley E. Barry, Jeremy R. Jackson, Grace E. Asuelime, Hongwei Wu, Jianping Sun, Zesheng Wan, Jemily Malvar, Michael A. Sheard, Larry Wang, Robert C. Seeger, Eugene S. Kim
Vydáno 2018Artigo -
4
TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells Autor Hung C. Tran, Zesheng Wan, Michael A. Sheard, Jianping Sun, Jeremy R. Jackson, Jemily Malvar, Yibing Xu, Larry Wang, Richard Sposto, Eugene S. Kim, Shahab Asgharzadeh, Robert C. Seeger
Vydáno 2016Artigo
Vyhledávací nástroje:
Související témata
Biochemistry
Biology
Cancer research
Cell culture
Genetics
Neuroblastoma
In vitro
Medicine
Chemistry
Cytotoxic T cell
Cytotoxicity
Immunology
Internal medicine
Angiogenesis
Antibody-dependent cell-mediated cytotoxicity
Apoptosis
Biotechnology
Blockade
Cancer
Chemotherapy
Immunotherapy
In vivo
Mdm2
Molecular biology
NKG2D
Pathology
Pharmacology
Receptor
VEGF receptors
Vascular endothelial growth factor